A Predictive Model of the Health Benefits and Cost Effectiveness of Celiprolol and Atenolol in Primary Prevention of Cardiovascular Disease in Hypertensive Patients
Dr Richard J. Milne,Stephen Vander Hoorn,Rodney T. JacksonVolume:
12
Language:
english
Journal:
PharmacoEconomics
DOI:
10.2165/00019053-199712030-00010
Date:
September, 1997
File:
PDF, 2.48 MB
english, 1997